This work was supported by the National Natural Science Foundation of China (81973607 and 81573992).

The investigations described conformed to the Guidelines for the Care and Use of Laboratory Animals of the National Research Council and were approved by the Shanghai University of Traditional Chinese Medicine Animal Care and Use Committee. When performing the experiments, lab coats, disposable nitrile gloves, and goggles are required for safety purposes.
1. Preparation of solvents and estimation of naringenin required for in vivo application
<ol>
	<li>Prepare the following solvents...

<ol>
	<li>Stoye, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Solvents.">Solvents.</a> Ullmann's Encyclopedia of Industrial Chemistry. , (2000).</li><li>Bouchard, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimization+of+the+solvent-based+dissolution+method+to+sample+volatile+organic+compound+vapors+for+compound-specific+isotope+analysis.">Optimization of the solvent-based dissolution method to sample volatile organic compound vapors for compound-specific isotope analysis.</a> Journal of Chromatography A. 1520, 23-34 (2017).</li><li>Turner, P. V., Brabb, T., Pekow, C., Vasbinder, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Administration+of+substances+to+laboratory+animals:+routes+of+administration+and+factors+to+consider.">Administration of substances to laboratory animals: routes of administration and factors to consider.</a> Journal of the American Association for Laboratory Animal Science: JAALAS. 50 (5), 600-613 (2011).</li><li>Vandenberg, L. N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hormones+and+endocrine-disrupting+chemicals:+low-dose+effects+and+nonmonotonic+dose+responses.">Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.</a> Endocrine Reviews. 33 (3), 378-455 (2012).</li><li>Hern&#225;ndez-Aquino, E., Muriel, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Beneficial+effects+of+naringenin+in+liver+diseases:+Molecular+mechanisms.">Beneficial effects of naringenin in liver diseases: Molecular mechanisms.</a> World Journal of Gastroenterology. 24 (16), 1679-1707 (2018).</li><li>Den Hartogh, D. J., Tsiani, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antidiabetic+properties+of+naringenin:+A+citrus+fruit+polyphenol.">Antidiabetic properties of naringenin: A citrus fruit polyphenol.</a> Biomolecules. 9 (3), (2019).</li><li>Tutunchi, H., Naeini, F., Ostadrahimi, A., Hosseinzadeh-Attar, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin,+a+flavanone+with+antiviral+and+anti-inflammatory+effects:+A+promising+treatment+strategy+against+COVID-19.">Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.</a> Phytotherapy Research. 34 (12), 3137-3147 (2020).</li><li>Zaidun, N. H., Thent, Z. C., Latiff, A. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Combating+oxidative+stress+disorders+with+citrus+flavonoid:+Naringenin.">Combating oxidative stress disorders with citrus flavonoid: Naringenin.</a> Life Sciences. 208, 111-122 (2018).</li><li>Tsuhako, R., Yoshida, H., Sugita, C., Kurokawa, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+suppresses+neutrophil+infiltration+into+adipose+tissue+in+high-fat+diet-induced+obese+mice.">Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice.</a> Journal of Natural Medicines. 74 (1), 229-237 (2020).</li><li>Annadurai, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antihyperglycemic+and+anti-oxidant+effects+of+a+flavanone,+naringenin,+in+streptozotocin-nicotinamide-induced+experimental+diabetic+rats.">Antihyperglycemic and anti-oxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats.</a> Journal of Physiology and Biochemistry. 68 (3), 307-318 (2012).</li><li>Li, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+improves+insulin+sensitivity+in+gestational+diabetes+mellitus+mice+through+AMPK.">Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.</a> Nutrition &amp; Diabetes. 9 (1), 28 (2019).</li><li>Devan, S., Janardhanam, V. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+Naringenin+on+metabolic+markers,+lipid+profile+and+expression+of+GFAP+in+C6+glioma+cells+implanted+rat's+brain.">Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.</a> Annals of Neurosciences. 18 (4), 151-155 (2011).</li><li>Burke, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+enhances+the+regression+of+atherosclerosis+induced+by+a+chow+diet+in+Ldlr-/-+mice.">Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr-/- mice.</a> Atherosclerosis. 286, 60-70 (2019).</li><li>Assini, J. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+prevents+obesity,+hepatic+steatosis,+and+glucose+intolerance+in+male+mice+independent+of+fibroblast+growth+factor+21.">Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.</a> Endocrinology. 156 (6), 2087-2102 (2015).</li><li>Alifarsangi, A., Esmaeili-Mahani, S., Sheibani, V., Abbasnejad, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+citrus+flavanone+naringenin+prevents+the+development+of+morphine+analgesic+tolerance+and+conditioned+place+preference+in+male+rats.">The citrus flavanone naringenin prevents the development of morphine analgesic tolerance and conditioned place preference in male rats.</a> The American Journal of Drug and Alcohol Abuse. 47 (1), 43-51 (2020).</li><li>Sirovina, D., Or&#353;oli&#263;, N., Gregorovi&#263;, G., Kon&#269;i&#263;, M. Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+ameliorates+pathological+changes+in+liver+and+kidney+of+diabetic+mice:+a+preliminary+study.">Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study.</a> Archives of Occupational Hygiene and Toxicology. 67 (1), 19-24 (2016).</li><li>Nguyen-Ngo, C., Willcox, J. C., Lappas, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anti-diabetic,+anti-inflammatory,+and+anti-oxidant+effects+of+Naringenin+in+an+In+vitro+human+model+and+an+in+vivo+murine+model+of+gestational+diabetes+mellitus.">Anti-diabetic, anti-inflammatory, and anti-oxidant effects of Naringenin in an In vitro human model and an in vivo murine model of gestational diabetes mellitus.</a> Molecular Nutrition &amp; Food Research. 63 (19), 1900224 (2019).</li><li>Ahmed, L. A., Obaid, A. A. Z., Zaki, H. F., Agha, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+adds+to+the+protective+effect+of+L-arginine+in+monocrotaline-induced+pulmonary+hypertension+in+rats:+favorable+modulation+of+oxidative+stress,+inflammation+and+nitric+oxide.">Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.</a> European Journal of Pharmaceutical Sciences. 62, 161-170 (2014).</li><li>Park, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naringenin+ameliorates+kainic+acid-induced+morphological+alterations+in+the+dentate+gyrus+in+a+mouse+model+of+temporal+lobe+epilepsy.">Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy.</a> Neuroreport. 27 (15), 1182-1189 (2016).</li><li>Matsui, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Early-stage+Type+2+diabetes+mellitus+impairs+erectile+function+and+neurite+outgrowth+from+the+major+pelvic+ganglion+and+downregulates+the+gene+expression+of+neurotrophic+factors.">Early-stage Type 2 diabetes mellitus impairs erectile function and neurite outgrowth from the major pelvic ganglion and downregulates the gene expression of neurotrophic factors.</a> Urology. 99, 1-7 (2017).</li><li>Sharma, G., Ashhar, M. U., Aeri, V., Katare, D. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+and+characterization+of+late-stage+diabetes+mellitus+and+-associated+vascular+complications.">Development and characterization of late-stage diabetes mellitus and -associated vascular complications.</a> Life Sciences. 216, 295-304 (2019).</li><li>Rowe, R. C., Sheskey, P. J., Owen, S. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Handbook of Pharmaceutical Excipients. , (2003).</li><li>Fallahi, F., Roghani, M., Moghadami, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Citrus+flavonoid+naringenin+improves+aortic+reactivity+in+streptozotocin-diabetic+rats.">Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats.</a> Indian Journal of Pharmacology. 44 (3), 382-386 (2012).</li><li>Liu, F., Yang, H., Zhou, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparison+of+the+characteristics+of+induced+and+spontaneous+db/db+mouse+models+of+type+2+diabetes+mellitus.">Comparison of the characteristics of induced and spontaneous db/db mouse models of type 2 diabetes mellitus.</a> Acta Laboratorium Animalis Scientia Sinica. 22 (6), 54-59 (2014).</li><li>Liu, S., Dong, J., Bian, Q. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+dual+regulatory+effect+of+naringenin+on+bone+homeostasis+in+two+diabetic+mice+models.">A dual regulatory effect of naringenin on bone homeostasis in two diabetic mice models.</a> Traditional Medicine and Modern Medicine. 03 (02), 101-108 (2020).</li><li>Sun, C., Wu, Z., Wang, Z., Zhang, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+ethanol/water+solvents+on+phenolic+profiles+and+anti-oxidant+properties+of+beijing+propolis+extracts.">Effect of ethanol/water solvents on phenolic profiles and anti-oxidant properties of beijing propolis extracts.</a> Evidence-Based Complementary and Alternative Medicine. 2015, 595393 (2015).</li><li>Huaman-Castilla, N. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+impact+of+temperature+and+ethanol+concentration+on+the+global+recovery+of+specific+polyphenols+in+an+integrated+HPLE/RP+process+on+carm&#233;n&#232;re+pomace+extracts.">The impact of temperature and ethanol concentration on the global recovery of specific polyphenols in an integrated HPLE/RP process on carm&#233;n&#232;re pomace extracts.</a> Molecules. 24 (17), (2019).</li><li>van Thriel, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Toxicology+of+solvents+(including+alcohol).">Toxicology of solvents (including alcohol).</a> Reference Module in Biomedical Sciences. , (2014).</li><li>Linakis, J. G., Cunningham, C. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effects+of+concentration+of+ethanol+injected+intraperitoneally+on+taste+aversion,+body+temperature,+and+activity.">Effects of concentration of ethanol injected intraperitoneally on taste aversion, body temperature, and activity.</a> Psychopharmacology. 64 (1), 61-65 (1979).</li><li>Magwaza, L. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+methods+for+extracting+and+quantifying+phenolic+compounds+in+citrus+rinds.">Rapid methods for extracting and quantifying phenolic compounds in citrus rinds.</a> Food Science &amp; Nutrition. 4 (1), 4-10 (2016).</li><li>Smith, E. R., Hadidian, Z., Mason, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+single--and+repeated--dose+toxicity+of+dimethyl+sulfoxide.">The single--and repeated--dose toxicity of dimethyl sulfoxide.</a> Annals of the New York Academy of Sciences. 141 (1), 96-109 (1967).</li><li>Colucci, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=New+insights+of+dimethyl+sulphoxide+effects+(DMSO)+on+experimental+in+vivo+models+of+nociception+and+inflammation.">New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation.</a> Pharmacological Research. 57 (6), 419-425 (2008).</li><li>Kawakami, K., Oda, N., Miyoshi, K., Funaki, T., Ida, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Solubilization+behavior+of+a+poorly+soluble+drug+under+combined+use+of+surfactants+and+co-solvents.">Solubilization behavior of a poorly soluble drug under combined use of surfactants and co-solvents.</a> European Journal of Pharmaceutical Sciences. 28 (1-2), 7-14 (2006).</li></ol>

The authors have nothing to disclose.

The preparation of phytochemical solution is the basis for its application in vivo. In this protocol, the preparation of naringenin solution was demonstrated by using different solvents, such as ethanol, DMSO, Tween 80, and 0.9% PS. The solution in completely dissolved status needs to be further monitored by allowing it to remain at room temperature for some extended hours, and then filtered before being used in vivo.
Solvent determination is a critical step in this protocol....

With increasing studies concerning the use of phytochemical compounds for drug screening, approaches to prepare phytochemical solutions to evaluate their optimal effects are worth giving attention to. Many aspects such as the dissolution methodology, dosage, and concentration&#160;are to be considered when preparing the compound1.
Solvent-based dissolution is widely used for organic compound preparation1. The commonly used solvents include water, oil, dimethyl sulfoxide (DMSO), methanol, ethanol, formic acid, Tween, glycerin, etc2. Although a suspension with undissolved substances is acceptable when the compound is administered by gastric gavage, a fully dissolved solute is critical for intravenous administration. Since oil solution, suspension, and emulsion can cause capillary embolisms, an aqueous solution for compound preparation is suggested, especially when administering intravenous, intramuscular, and intraperitoneal injections3.
The effective dose range varies among compounds and even among diseases treated with the same compound. Determinations of the effective and the safe dose and the concentration are dependant on literature and preliminary experiments4. Here, the preparation of the compound naringenin is demonstrated as an example.
Naringenin (4,5,7-trihydroxy-flavanone), a polyphenolic compound, has been studied in disease treatment for its hepatoprotective5, antidiabetic6, anti-inflammatory7, and anti-oxidant activities8. For in vivo applications, the oral administration of naringenin is commonly used. Previous studies reported preparing naringenin solution in 0.5%-1% carboxymethyl cellulose, 0.5% methylcellulose dose, 0.01% DMSO, and physiological saline (PS) at 50-100 mg/kg, administered by oral gavage9,10,11,12. Besides, other studies have reported supplementing naringenin with chow at 3% (wt/wt) for oral intake at a dose of 3.6 g/kg/d13,14. Studies have also reported using ethanol (0.5% v/v), PS, and DMSO to dissolve naringenin for intraperitoneal injection at 10-50 mg/kg15,16,17,18. In a study of temporal lobe epilepsy, mice received an injection of naringenin suspended in 0.25% carboxymethyl cellulose dissolved in PS19. Though these studies report the use of different solvents to prepare naringenin solutions, further details, such as dissolving status and animal response, have not been reported.
This protocol introduces a procedure for preparing naringenin solution for in vivo application in diabetic-induced osteoporosis. The preparation of the injection solution includes preparing solvents and compounds, dosage estimation, dissolution process, and filtration. The dosage was determined based on literature research and preliminary experiments by monitoring mice after administering injections every day for 3 days and modifying the dosage according to mouse behaviors. The final chosen concentration (20 mg/kg b.w.) was administered intraperitoneally 5 days per week for 8 weeks in a high-fat diet and streptozotocin (STZ)-induced diabetic mice20,21. The effects of naringenin in diabetic osteoporosis were evaluated by blood glucose testing, micro-CT, tartrate-resistant acid phosphatase (TRAP) staining, and enzyme-linked immunosorbent assay (ELISA).
Overall, it was observed that naringenin at a concentration range of 40-400 mg/mL did not completely dissolve in either ethanol or DMSO or 5% (ethanol or DMSO) plus 95% PS (v/v). However, naringenin dissolved completely in a mixture of 3.52% DMSO, 3.52% Tween 80, and 92.96% PS. The detailed procedure will help researchers to prepare the compound as an injection solution for in vivo application.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>1.5 mL&#160; microtubes</td>
			<td>Corning Science (Wujiang) Co.</td>
			<td>23218392</td>
			<td>Holding liquid</td>
		</tr>
		<tr>
			<td>Automatic Dehydrator</td>
			<td>Leica Microsystems (Shanghai) Co.</td>
			<td>LEICA ASP 300S</td>
			<td>Dehydrate samples</td>
		</tr>
		<tr>
			<td>Blood glucose test strips</td>
			<td>Johnson &#38; Johnson (China) Medical Equipment Co.</td>
			<td>4130392</td>
			<td></td>
		</tr>
		<tr>
			<td>Centrifuge</td>
			<td>MIULAB</td>
			<td>Minute centrifuge</td>
			<td>Centrifugal solution</td>
		</tr>
		<tr>
			<td>Dehydrator</td>
			<td>Leica Microsystems (Shanghai) Trading Co.</td>
			<td>LEICA&#160; ASP300S</td>
			<td>Dehydration</td>
		</tr>
		<tr>
			<td>DMSO</td>
			<td>Sangon Biotech (Shanghai ) Co.,Ltd.</td>
			<td>E918BA0041</td>
			<td>Co-Solvent</td>
		</tr>
		<tr>
			<td>ELISA assay kit</td>
			<td>Elabscience Biotechnology Co.,Ltd</td>
			<td>Mouse COL1(Collagen Type I) ELISA Kit: E-EL-M0325c 
			Mouse&#160; CTX I ELISA Kit: E-EL-M0366c 
			Mouse PICP ELISA Kit: E-EL-M0231c 
			Mouse PINP ELISA Kit: E-EL-M0233c</td>
			<td></td>
		</tr>
		<tr>
			<td>Ethanol absolute</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>10009218</td>
			<td>Co-Solvent</td>
		</tr>
		<tr>
			<td>Ethylene glycol monoethyl ether</td>
			<td>Sangon Biotech (Shanghai ) Co.,Ltd.</td>
			<td>A501118-0500</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Ethylenediaminetetraacetic acid (EDTA)</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>10009617</td>
			<td>Decalcification</td>
		</tr>
		<tr>
			<td>Filter</td>
			<td>Merck Millpore LTD.</td>
			<td>Millex-GP, 0.22 &#181;m</td>
			<td>filter solution</td>
		</tr>
		<tr>
			<td>Glacial acid</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>10000218</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Glucose meter</td>
			<td>Johnson &#38; Johnson (China) Medical Equipment Co.</td>
			<td>One Touch Ultra Vue</td>
			<td>Serial number:COJJG8GW</td>
		</tr>
		<tr>
			<td>Grinder</td>
			<td>Shanghaijingxin Experimental Technology</td>
			<td>Tissuelyser-24</td>
			<td></td>
		</tr>
		<tr>
			<td>Hematoxylin</td>
			<td>Nanjing Jiancheng Bioengineering Institute</td>
			<td>D005</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Insulin syringe</td>
			<td>Shanghai Kantaray Medical Devices Co.</td>
			<td>0.33 mm x 13 mm, RW LB</td>
			<td>Intraperitoneal injection</td>
		</tr>
		<tr>
			<td>L-(+) tartaric acid</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>100220008</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Microscope</td>
			<td>OLYMPUS</td>
			<td>sz61</td>
			<td>Observation</td>
		</tr>
		<tr>
			<td>Microtome</td>
			<td>Leica Microsystems (Shanghai) Trading Co.</td>
			<td>LEICA RM 2135</td>
			<td>Section</td>
		</tr>
		<tr>
			<td>Mini centrifuge</td>
			<td>Hangzzhou Miu Instruments Co., Ltd.</td>
			<td>&#160;Mini-6KC</td>
			<td>Centrifuge</td>
		</tr>
		<tr>
			<td>Naphthol AS-BI phosphate</td>
			<td>SIGMA-ALDRICH</td>
			<td>BCBS3419</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Naringenin</td>
			<td>Jiangsu Yongjian Pharmaceutical Co.,Ltd</td>
			<td>102764</td>
			<td>Solute</td>
		</tr>
		<tr>
			<td>Paraffin Embedding station</td>
			<td>Leica Microsystems (Shanghai) Co.</td>
			<td>LEICA&#160; EG 1150 H, LEICA&#160; EG 1150 C</td>
			<td>Embed&#160; samples</td>
		</tr>
		<tr>
			<td>Pararosaniline base</td>
			<td>BBI Life Sciences</td>
			<td>E112BA0045</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Pipettes</td>
			<td>eppendorf</td>
			<td>2&#8211;20 &#181;L, 100&#8211;1000 &#181;L, 20&#8211;200 &#181;L</td>
			<td>&#160; transferre Liquid</td>
		</tr>
		<tr>
			<td>Plate reader</td>
			<td>BioTek Instruments USA, Inc.</td>
			<td>BioTek CYTATION 3 imaging reader</td>
			<td>ELISA</td>
		</tr>
		<tr>
			<td>Resin</td>
			<td>Shanghai Yyang Instrument Co., Ltd.</td>
			<td>Neutral balsam</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>saline (0.9 PS)</td>
			<td>Baxter Healthcare (Shanghai) Co.,Ltd</td>
			<td>A6E1323</td>
			<td>Solvent</td>
		</tr>
		<tr>
			<td>Sodium acetate anhydrous</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>Merck-1.06268.0250 | 250g</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Sodium nitrite</td>
			<td>Sinopharm Chemical ReagentCo., Ltd</td>
			<td>10020018</td>
			<td>TRAP staining</td>
		</tr>
		<tr>
			<td>Tween-80</td>
			<td>Sangon Biotech (Shanghai ) Co.,Ltd.</td>
			<td>E819BA0006</td>
			<td>Emulsifier</td>
		</tr>
		<tr>
			<td>Zirconia beads</td>
			<td>Shanghaijingxin Experimental Technology</td>
			<td>11079125z 454g</td>
			<td>Grinding</td>
		</tr>
	</tbody>
</table>

preparation of naringenin solution for in vivo application

The preparation of a compound (phytochemical) solution is an overlooked but critical step prior to its application in studies such as drug screening. The complete solubilization of the compound is necessary for its safe use and relatively stable results. Here, a protocol for preparing naringenin solution and its intraperitoneal administration in a high-fat diet and streptozotocin (STZ)-induced diabetic model is demonstrated as an example. A small amount of naringenin (3.52-6.69 mg) was used to test its solubilization in solvents, including ethanol, dimethylsulfoxide (DMSO), and DMSO plus Tween 80 reconstituted in physiological saline (PS), respectively. Complete solubilization of the compound is determined by observing the color of the solution, the presence of precipitates after centrifugation (2000 x g for 30 s), or allowing the solution to stand for 2 h at room temperature (RT). After obtaining a stable compound/phytochemical solution, the final concentration/amount of the compound required for in vivo studies can be prepared in a solvent-only (no PS) stock solution, and then diluted/mixed with PS as desired. The antidiabetic osteoporotic effects of naringenin in mice (intraperitoneal administration at 20 mg/kg b.w., 2 mg/mL) were assessed by measuring blood glucose, bone mass (micro-CT), and bone resorption rate (TRAP staining and ELISA). Researchers looking for detailed organic/phytochemical solution preparations will benefit from this technique.

The bodyweight of the high-fat diet-fed and STZ-induced diabetic mice was found to decrease when compared with that of the control groups from 0-8 weeks after STZ treatment. The weight loss of naringenin-treated mice was significant compared to the nontreated mice (STZ group) at week 4. The control and STZ groups were administered with the same volume of PS (Table 1). The blood glucose level in diabetic mice dramatically increased within 1 month after STZ induction. It then automatically decreased to a l...

Watch this Scientific Journal Video about Preparation of Naringenin Solution for In Vivo Application at JoVE.com

Preparation of Naringenin Solution for In Vivo Application

Here, the protocol presents the preparation of naringenin solution for in vivo intraperitoneal administration. Naringenin is fully dissolved in a mixture of dimethylsulfoxide, Tween 80, and saline. The antidiabetic osteoporotic effects of naringenin were assessed by blood glucose testing, tartrate-resistant acid phosphatase staining, and enzyme-linked immunosorbent assay.

Preparation of Naringenin Solution for In Vivo Application

The preparation of a compound (phytochemical) solution is an overlooked but critical step prior to its application in studies such as drug screening. The ...

With increasing studies concern the phytochemical components for drug screening approaches to prepare phytochemical solution for evaluation of optimal effects, I was giving attention to the advantages of this protocol as simple operation and low cost. This protocol will benefit the researchers dealing with the drug screening of pharmacology. We suggest starting with a small amount of phytochemical compound for preliminary experiments, considering the consumption cost.Second, using an insulin syringe over a regular syringe is recommended To prepare a two milligrams per milliliter naringenin solution in ethanol, weigh 3.52 milligrams of naringenin powder and add it to a two milliliter tube. Quickly spin the tube to settle the powder at the bottom of the tube. Next, add 8.8 microliters of 100%ethanol to the tube to prepare a 0.5%solution.Then add 79.2 microliters of 100%ethanol to the tube to prepare a 5%solution. Next, add 1.672 milliliters of 0.9%physiological saline to the tube containing the 5%solution. This will produce an emulsion.Then centrifuge refused the tube to check whether the naringenin is completely dissolved in the solution. White precipitates of undissolved naringenin may appear in the solution. Next, to prepare a two milligram per milliliter naringenin solution in DMSO, weigh 3.95 milligrams of naringenin powder and add it into a two milliliter tube.After a quick spin, add 9.8 milliliters of DMSO to the tube to prepare 8.5%solution. Then add 88.2 microliters of DMSO to the tube to prepare a 5%solution. Next, add 1.877 milliliters of 0.9%saline to the solution.This will result in an emulsion. Centrifuge the solution to check whether the naringenin is completely dissolved. White precipitates have undissolved naringenin may appear in the solution.Next, to prepare a two milligrams per milliliter naringenin solution in Tween 80 and DMSO, weigh 6.69 milligrams of naringenin powder and add it into a five milliliter tube. Quickly spin down the tube, and add 117.7 microliters of DMSO to prepare a 3.5%solution. Then add 117.7 microliters of Tween 80 to the solution to attain a 3.5%Tween 80 and 3.5%DMSO concentration.Slowly add this solution to another five milliliter tube containing 3109.6 microliters of 0.9%saline and shake well to obtain a clear naringenin solution. After two hours, the solution will remain clear without any visible precipitates. To administer the naringenin solution, lift a five-week-old C57 black six male mouse by the base of its tail and place it on a solid surface positioning its tail back gently.Next, grasp the scruff of the neck behind the ears with the left thumb and index finger and position the tail between the little and ring finger. Keep the mouse in a supine position with its posterior end slightly elevated. To inject the naringenin solution, grasp the skin on the mouse's back so that the abdominal skin is taut.Then push the needle into the lower right or left quadrant of the abdomen at a 10-degree angle. to avoid hitting the bladder, liver or other internal organs. Run the needle subcutaneously in a cranial direction for three to five millimeters, then insert it at a 45-degree angle into the abdominal cavity.Once the needle passes through the abdominal wall, slowly push the solution. After the injection, slowly pulled the needle out, rotating it slightly to prevent leakage. To perform a blood glucose test, open the test strips and mark the date.Make a small puncture on the lateral tail vein with a 25-gauge needle prick and squeeze out a drop of blood. After wiping the drop of blood with tissue paper, squeeze out another drop of blood and collect it on the edge of the test strip. Read and record the result displayed on the glucose meter.Body weight of the high fat diet fed and streptozotocin-induced diabetic mice was decreased compared to that of control group mice zero to eight weeks after a streptozotocin treatment. At the fourth week, the weight loss of naringenin-treated mice was significant compared to non-treated mice. Blood glucose level in the diabetic mice dramatically increased within one month after streptozotocin induction.After two months, it automatically decreased to a level observed two months ago. In contrast, naringenin treatment lowered the blood glucose levels by 51.8%at one month and 34.8%at two months compared to STZ. Compared to controls, the streptozotocin-induced diabetic mice exhibited bone loss as indicated by a decrease in the bone volume by tissue volume and the number of trabecula.Meanwhile, naringenin treatment significantly rescued the bone loss. Osteoclast activity shown by osteoclast number per trabecular bone area was increased in diabetic mice although no statistical significance was observed between the control and the disease models. TRAP staining of trabecular bone and osteoclasts of control and streptozotocin-induced mice is shown here.Naringenin treatment significantly decreased osteoclast activities. In the diabetic animals, the C-terminal telopeptide of type one collagen was elevated by 68.09%and the N-terminal propeptide of type one Pro-Collagen was elevated by 204.88%indicating a dramatic increase in the bone resorption rate. However, naringenin treatment significantly decreased both indicators of the bone resorption rate.so it is challenging to pipette accurate dosage. Cutting the tip off makes pipetting easier and more accurate. Alternatively, the required volume can be converted to a mass, which can be later easily.The fasting time of all animals before each bladder glucose experiment must remain the thing during the entire experiment.

preparation-of-naringenin-solution-for-in-vivo-application

Research

JoVE Journal

Medicine

3.1K Görüntüleme.  Shanghai University of Traditional Chinese Medicine. Optimal etkilerin değerlendirilmesi için fitokimyasal çözelti hazırlamak üzere ilaç tarama yaklaşımları için fitokimyasal bileşenler ile ilgili artan çalışmalarla, bu protokolün basit çalışma ve düşük maliyet olarak avantajlarına dikkat çekiyordum. Bu protokol, farmakolojinin ilaç taraması ile ilgilenen araştırmacılara fayda sağlayacaktır. Tüketim maliyetini göz önünde bulundurarak, ön deneyler için az miktarda fitokimyasal bileşikle başlamanızı öneri...